Aurinia Pharmaceuticals
AUPH
#4854
Rank
NZ$3.64 B
Marketcap
NZ$28.36
Share price
4.71%
Change (1 day)
127.58%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): NZ$0.23 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.29 Billion. In 2025 the company made an earning of NZ$0.20 Billion, an increase over its 2024 earnings that were of NZ$21.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.23 B14.26%
2025 NZ$0.20 B864.64%
2024 NZ$21.47 M-116.44%
2023 -NZ$0.14 Billion-31.8%
2022 -NZ$0.2 Billion-39.4%
2021 -NZ$0.32 Billion61.9%
2020 -NZ$0.2 Billion-9.73%
2019 -NZ$0.22 Billion92.65%
2018 -NZ$0.12 Billion36.39%
2017 -NZ$82.3 Million106.29%
2016 -NZ$39.9 Million-15.4%
2015 -NZ$47.16 Million65.84%
2014 -NZ$28.44 Million129.82%
2013 -NZ$12.38 Million-26.6%
2012 -NZ$16.86 Million
2010 -NZ$9.55 Million-39.22%
2009 -NZ$15.71 Million-43.78%
2008 -NZ$27.94 Million-53.19%
2007 -NZ$59.68 Million42.97%
2006 -NZ$41.74 Million-23.03%
2005 -NZ$54.23 Million36.1%
2004 -NZ$39.85 Million172.57%
2003 -NZ$14.62 Million484.61%
2002 -NZ$2.51 Million
2000 -NZ$11.88 Million453.81%
1999 -NZ$2.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$9.01 B 3,636.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-NZ$38.69 Million-116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-NZ$9.6 Million-103.97%๐Ÿ‡บ๐Ÿ‡ธ USA